Reed G

Language: English
References: 0
Page: 10-13
PDF size: 67.17 Kb.

Text Extraction

He sips mate, the bitter brew of his native Uruguay as he converses at PAHO's offices in Havana. Yet, he already feels at home here, says Dr Di Fabio, who took up his post in July of 2011. This is not surprising, since his connection to Cuban health care and research predates his arrival by two decades. In 1992–93, he worked on the Americas' vaccine system (SIREVA) for PAHO and became involved in monitoring cooperation in vaccine regulatory issues, quality and production. From that period emerged one of Latin America's great achievements: Vicente Vérez Bencomo's development at the University of Havana of the world's first Haemophilus influenzae type b (Hib) synthetic-antigen vaccine. Dr Di Fabio came to Cuba often to follow up on the vaccine's regulatory process, production, and quality control for PAHO.